Abstract

BackgroundHistopathological diagnosis is important for prognostication and choice of treatment in patients with cancer in the lung. Metastases to the lungs are common and need to be distinguished from primary lung cancer. Furthermore, cases with synchronous or metachronous primary lung cancers (although infrequent) are often handled differently than cases with lung cancer with intrapulmonary metastasis or relapse, respectively. In some cases, morphology and immunohistochemical staining is not sufficient for certain diagnosis.MethodsThe present study included six cases where molecular genetic analysis in form of pyrosequencing or targeted next-generation sequencing was of value for certain diagnosis of selected tumours in the lung.ResultsTwo of the included cases were rare metastases to the lung; colorectal cancer with IHC profile consistent with primary lung cancer and malignant adenomyoepithelioma of the breast, respectively, where molecular genetic analysis was of aid for proving the relationship to the primary tumour. The other four cases were multiple lung adenocarcinomas where molecular genetic analysis was of aid to distinguish between intrapulmonary metastasis and synchronous tumour.ConclusionsComparison of molecular genetic profile may be an important tool for determination of relationship between tumours in some situations and should always be considered in unclear cases. Further studies on concordance and discordance of molecular genetic profiles between spatially or temporally different tumours with common origin may be helpful for improved diagnostics of pulmonary tumours.

Highlights

  • Histopathological diagnosis is important for prognostication and choice of treatment in patients with cancer in the lung

  • We present six cases where molecular genetic analysis aided in the diagnostics of pulmonary tumours

  • Correct diagnosis is important as there is a difference in treatment and prognosis if a separate lung cancer with liver metastasis appears in a patient with previous rectal cancer instead of metastasis to the liver and lung from the rectal cancer

Read more

Summary

Introduction

Histopathological diagnosis is important for prognostication and choice of treatment in patients with cancer in the lung. Metastases to the lungs are common and need to be distinguished from primary lung cancer. Histopathological diagnosis is important for choice of treatment in patients with cancer in the lung. Metastases to the lungs are common and need to be distinguished from primary lung cancer, and the treatment of primary lung cancer is dependent on histopathological type [1,2,3]. The basis for histopathological diagnosis is morphology, with the addition of immunohistochemical (IHC) staining when needed. Sometimes the morphological appearance may be indistinct and the results of IHC staining may differ from the typical, with for example positive GATA3 reported in 8% of lung adenocarcinomas [11,12,13,14,15,16]. There is a need for additional diagnostic analyses or markers, at least in some cases

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call